Learn about polymyalgia rheumatica, temporal arteritis, their symptoms, causes, and treatment options to manage pain, ...
Topline data were announced from a phase 3 trial evaluating secukinumab in patients with polymyalgia rheumatica.
In patients with relapsing polymyalgia rheumatica, sarilumab with a rapid glucocorticoid taper regimen of 14 weeks led to greater improvements in patient-reported outcomes of health-related quality of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback